
NSAIDS AND PENTOXIFYLLINE
The manufacturers of ketorolac say that there is an increased risk of bleeding events if pentoxifylline is given concurrently.
The manufacturers say that concurrent use should be avoided.
The manufacturers say that concurrent use should be avoided.